Advances in Novel Drug Delivery Systems

Abstract

The increasing need for treatments that are safer, more patient-friendly, and more effective has given NDDS significant impetus in recent years. Due to rapid metabolism, enzymatic degradation, or poor permeability across biological barriers, traditional dosage forms frequently fall short of achieving optimal therapeutic levels. In order to address these problems, NDDS uses novel materials and delivery systems that make it easier for medications to overcome physiological obstacles. For instance, hydrophilic and lipophilic medications can be encapsulated in nanocarrier systems like liposomes and polymeric nanoparticles to improve cellular uptake while preventing degradation. Active targeting, in which ligands direct the medication directly to diseased tissues to reduce off-target effects, is made possible by their capacity to be surface-modified. The drawbacks of conventional drug delivery, such as low bioavailability, instability, rapid drug release, and fluctuating plasma concentrations, are addressed by novel drug delivery systems (NDDS), a state-of-the-art technique. This study emphasises the evolution, significance, and applications of NDDS in modern therapies. The article discusses a range of carrier-based systems, including liposomes, nanoparticles, microspheres, and niosomes, as well as transdermal techniques like sonophoresis, osmotic pumps, and microencapsulation. The key features, advantages, disadvantages, and factors influencing NDDS performance are examined. Particular focus is placed on the composition, production processes, and potential for targeted, controlled, and long-term drug delivery of polymeric nanoparticles and liposomes. Thanks to advancements, NDDS plays a revolutionary role in improving therapeutic efficacy, patient compliance, and overall therapy outcome. In a similar vein, sophisticated transdermal delivery methods improve therapeutic consistency by avoiding first-pass metabolism and offering sustained release. The skin barrier is momentarily disrupted by methods like sonophoresis and microneedle arrays, allowing larger or hydrophilic drug molecules to effectively penetrate. Osmotic pumps provide long-lasting and consistent dosing by ensuring controlled release based on osmotic pressure differences. NDDS continues to develop towards precision and personalised medicine as research advances, providing individualised treatments that are in line with the needs of each patient and particular disease profiles. This development emphasises how important NDDS will be in determining how pharmaceutical therapy develops in the future.